BT-001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and non-injected lesionsData support further development of BT-001 in solid tumors ...
Belfast Live on MSN
Dr Leah Totton reveals concerns behind 'worrying' cosmetic tourism
The Apprentice star from Derry has opened up about concerns in the ongoing cosmetic tourism epidemic, admitting that there ...
Tecentriq reduced the risk of death by 41% and the risk of disease recurrence or death by 36% compared with placebo –– ...
Alphamab Oncology (stock code: 9966.HK) announced that two latest clinical data on biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 for the treatment of primary platinum-refractory ...
Meitheal Pharmaceuticals, Inc. ("Meitheal"), a fully integrated biopharmaceutical company based in Chicago and focused on the ...
Independent.ie on MSN
Man runs Royal Parks Half Marathon while undergoing blood cancer treatment
A man diagnosed with a blood cancer in his 20s, and told he may only have three days to live, has run a half marathon while undergoing treatment. Callum Stroud, 29, from Kent, took part in this year’s ...
KEYTRUDA is indicated for the treatment of patients with resectable (tumors ≥4 cm or node positive) NSCLC in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback